0.3222

0.37% 0.0012

Pre-market: .32 -0.0022 -0.68%

IGC Pharma Inc (IGC)

Overview News Price History Option Chain Discussions Forecast Stock Split

IGC Pharma Inc stock is traded at $0.3222, with a volume of 338.39K. It is up +0.37% in the last 24 hours and up +21.54% over the past month. India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.

Previous Close:

$0.321

Open:

$0.3249

24h Volume:

338.39K

Relative Volume:

0.33

Market Cap:

$31.83M

Revenue:

$1.20M

Net Income/Loss:

$-5.34M

P/E Ratio:

-5.2136

EPS:

-0.0618

Net Cash Flow:

$-6.27M

1W Performance:

+2.78%

1M Performance:

+21.54%

6M Performance:

-17.38%

1Y Performance:

+7.40%

1-Day Range:

$0.3178

$0.3296

1-Week Range:

$0.3003

$0.34

52-Week Range:

$0.242

$0.4985

IGC Pharma Inc Stock (IGC) Company Profile

Name

IGC Pharma Inc

Sector

Healthcare (1106)

Industry

Biotechnology (615)

Phone

301-983-0998

Address

4336 Montgomery Avenue, Bethesda, MD

Employee

Twitter

@IGCIR

Next Earnings Date

2026-06-26

Latest SEC Filings

IGC's Discussions on Twitter

Compare IGC vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IGC IGC Pharma Inc	0.3222	31.83M	1.20M	-5.34M	-6.27M	-0.0618
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

IGC Pharma Inc Stock (IGC) Latest News

May 01, 2026

IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill

May 01, 2026

Apr 30, 2026

MSN Money - MSN

Apr 30, 2026

Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification - marketscreener.com

Apr 30, 2026

FOCUS-Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification - Sahm

Apr 30, 2026

Apr 29, 2026

Cannabinoid Clinical Trials See Significant Growth for New… - Hemp Gazette

Apr 29, 2026

Cannabinoid Clinical Trials Gain Momentum: 50+ Companies Le… - Hemp Gazette

Apr 29, 2026

IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase - BioSpace

Apr 29, 2026

Apr 28, 2026

As Alzheimer’s trial nears completion, IGC turns to caregivers - Stock Titan

Apr 28, 2026

Apr 25, 2026

New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global - Scott Coop

Apr 25, 2026

Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Apr 25, 2026

Apr 24, 2026

IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment Advances Toward Completion - itemonline.com

Apr 24, 2026

IGC Pharma Secures Psilocybin Research Authorization, Expanding Focus on Neuropsychiatric Symptoms in Dementia - Times Argus

Apr 24, 2026

IGC Should I Buy - Intellectia AI

Apr 24, 2026

Apr 23, 2026